eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Ovarian, Ovarian Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
ROS↑, TrxR↓, MMP↓, Apoptosis↑, eff↓, Casp3↑, Casp7↑, DNAdam↑, eff↑, GSH↓, angioG↓, ChemoSen↑, cl‑PARP↑, eff↑,
| - |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
- |
in-vitro, |
Ovarian, |
TOV-21G |
|
|
|
TumCG↓, TumCCA↑, ROS↑, DNAdam↑, Chk2↑, Dose∅, p‑γH2AX↑, CDC25↓, CHK1↓, cycD1/CCND1↓, eff↓, 12LOX↓,
| - |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
- |
in-vitro, |
Ovarian, |
A2780S |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
Apoptosis↑, Ferroptosis↑, Ca+2↓, CaMKII
↓, Akt↓, mTOR↓, Hif1a↓, ROS↑, ChemoSen↑, Casp3↑, Casp9↑, BAX↑, Bcl-2↓, Cyt‑c↑, GlucoseCon↓, lactateProd↓, Pyruv↓, GLUT1↓, HK2↓, PFKP↓, Glycolysis↓, Hif1a↓, p‑Akt↓, p‑mTOR↓, Iron↑, lipid-P↑, MDA↑, ROS↑, H2O2↑, mtDam↑, GSH↓, GPx↓, GPx4↓, NADPH/NADP+↓, eff↓, FTH1↓, LC3‑Ⅱ/LC3‑Ⅰ↑, NCOA4↑, eff↓, TumCG↓,
| - |
vitro+vivo, |
Ovarian, |
SKOV3 |
|
|
|
ROS↑, eff↓, AntiCan↑, Apoptosis↑, tumCV↓, TumCG↓, TumCCA↑, LC3s↑, ERStress↑, Beclin-1↑, Bax:Bcl2↑, HER2/EBBR2↓, Akt↓, mTOR↓,
| - |
in-vitro, |
Ovarian, |
NA |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
AntiCan↑, Pyro↑, tumCV?, CellMemb↓, cl‑Casp3↑, GSDME-N↑, ROS?, p‑P53↑, eff↓, MMP↓, Bcl-2↓, BAX↑, mtDam↑, Cyt‑c↑, TumCG↓, CD4+↑, CD8+↑,
| - |
in-vitro, |
Ovarian, |
PA1 |
|
|
|
- |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
ROS↑, TumCP↓, GSH↓, selectivity↑, UPR↑, CHOP↑, ER Stress↑, GRP78/BiP↑, PERK↑, ATF6↑, eff↓, TumCG↓, Apoptosis↑, toxicity↓,
| - |
vitro+vivo, |
Ovarian, |
SKOV3 |
|
|
|
ROS↑, GSH↓, selectivity↑, mtDam↑, TumCD↑, OS↑, eff↑, *toxicity↓, H2O2↑, NO↑, eff↓, GPx↓, Dose↝, eff↑,
| - |
in-vitro, |
Ovarian, |
OVCAR-3 |
|
|
|
TumCD↑, TumCP↓, Apoptosis↑, Casp3↑, Casp9↑, Bcl-2↓, BAX↑, Akt↓, ERK↓, cMyc↓, p38↑, JNK↑, eff↓,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Ferroptosis↑, 1, GPx↓, 2, GPx4↓, 1, GSH↓, 4, H2O2↑, 2, Iron↑, 1, lipid-P↑, 1, MDA↑, 1, NADPH/NADP+↓, 1, ROS?, 1, ROS↑, 7, TrxR↓, 1,
Metal & Cofactor Biology ⓘ
FTH1↓, 1, NCOA4↑, 1,
Mitochondria & Bioenergetics ⓘ
CDC25↓, 1, MMP↓, 2, mtDam↑, 3,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, cMyc↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, HK2↓, 1, lactateProd↓, 1, PFKP↓, 1, Pyruv↓, 1,
Cell Death ⓘ
Akt↓, 3, p‑Akt↓, 1, Apoptosis↑, 5, BAX↑, 3, Bax:Bcl2↑, 1, Bcl-2↓, 3, Casp3↑, 3, cl‑Casp3↑, 1, Casp7↑, 1, Casp9↑, 2, Chk2↑, 1, Cyt‑c↑, 2, Ferroptosis↑, 1, GSDME-N↑, 1, JNK↑, 1, p38↑, 1, Pyro↑, 1, TumCD↑, 2,
Kinase & Signal Transduction ⓘ
CaMKII
↓, 1, HER2/EBBR2↓, 1,
Transcription & Epigenetics ⓘ
tumCV?, 1, tumCV↓, 1,
Protein Folding & ER Stress ⓘ
ATF6↑, 1, CHOP↑, 1, ER Stress↑, 1, ERStress↑, 1, GRP78/BiP↑, 1, PERK↑, 1, UPR↑, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, LC3‑Ⅱ/LC3‑Ⅰ↑, 1, LC3s↑, 1,
DNA Damage & Repair ⓘ
CHK1↓, 1, DNAdam↑, 2, p‑P53↑, 1, cl‑PARP↑, 1, p‑γH2AX↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
ERK↓, 1, mTOR↓, 2, p‑mTOR↓, 1, TumCG↓, 5,
Migration ⓘ
Ca+2↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, Hif1a↓, 2, NO↑, 1,
Barriers & Transport ⓘ
CellMemb↓, 1, GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 2, Dose↝, 1, Dose∅, 1, eff↓, 9, eff↑, 4, selectivity↑, 2,
Clinical Biomarkers ⓘ
HER2/EBBR2↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 2, OS↑, 1, toxicity↓, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 87
Pathway results for Effect on Normal Cells:
Functional Outcomes ⓘ
toxicity↓, 1,
Total Targets: 1
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:20 Cells:% prod#:% Target#:961 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page